TORONTO--(BUSINESS WIRE)--In celebration of Canada’s health science industry, Ontario Bioscience Innovation Organization (OBIO®) hosted it’s ninth annual leadership dinner at Toronto’s University Club on May 2. Attended by a prestigious group of investors, companies, MPPs and industry supporters the event celebrated the success of the OBIO Capital Access Advisory Program (CAAP®) with many of the high potential companies from the program’s first five years in attendance. The event was supported by Norton Rose Fulbright LLP and by Bloom Burton & Co.
The evening featured guest speaker Charles Plant, Senior Fellow, Impact Centre, University of Toronto and author of several papers on Canada’s technology industry including: “A Failure to Scale” published by the Impact Centre. Charles spoke about the inability of Canada’s innovation system to grow and scale companies and the critical issue of how funds are raised that often impedes their success. He also addressed the importance of early marketing and sales efforts if an invention is to create value and gain acceptance in the marketplace and in use by the consumer.
Representatives of industry were joined by two levels of Government: MPPs Bill Walker, John Fraser, Peggy Sattler and Catherine Fife; William Charnetski, Chief Health Innovation Strategist, Ministry of Health, and Alexia Touralias, Director General, Federal Economic Development Agency.
“Each year we engage our guests in a conversation about a different aspect of industry building and this year was no different.” said Gail Garland, President and CEO of OBIO. “Bringing companies together with investors, policy makers and mentors year after year has built a rich culture of engagement and debate. It is a privilege to host these events. Our sponsors and supporters deserve a big thank you for helping make this a success.”
The Ontario Bioscience Innovation Organization (OBIO®) founded in 2009, is a not-for-profit, membership-based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of Ontario’s human health technologies positioning Ontario as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.